B and T lymphocytes are generated from hematopoietic stem cells during both fetal and adult life.
ABSTRACT
B and T lymphocytes are generated from hematopoietic stem cells during both fetal and adult life. A critical unresolved issue is whether the differentiation pathways in lymphopoiesis are the same in fetal and adult animals or whether they differ, similar to the hemoglobin switch in erythropoiesis. We report here that a developmental switch occurs in B lymphopoiesis. We isolated "pro-B" cells (i.e., cells that have initiated, but not completed, heavy-chain gene rearrangement) from fetal and adult sources and investigated their B-cell progeny generated both in vitro and in vivo. Most of the cells from fetal liver, but few from adult bone marrow, expressed CD5. Further, fetal pro-B cells failed to generate cells expressing high levels of IgD in severe combined immunodeficiency mice, whereas adult pro-B cells gave rise to CD5-B cells bearing IgD at levels comparable to the bulk of cells in the spleen of adult mice. Thus, all committed B progenitors in fetal liver of day 16 gestation mice give rise to phenotypically distinct progeny when compared to cells at a comparable differentiation stage in the bone marrow of adult animals. We conclude that the cohort of B-lineage progenitors in early fetal development is committed to a differentiation pathway distinct from that seen in the adult.
Developmentally regulated differences in the cells that predominate in the hematopoietic system during fetal versus adult life have been observed in both the erythroid and lymphoid lineages. Erythrocytes produced during the fetal stage express the "i" cell surface antigen and possess a distinctive fetal hemoglobin (1) (2) (3) (4) (5) . T 
cells bearing the vS
T-cell receptor class are abundant in the fetal stage, but are rare in the adult (6) (7) (8) (9) . Phenotypic and functional differences in B cells present in early and adult stages of ontogeny have been documented (10) (11) (12) . Most B cells in neonatal mice express only low levels of IgD, unlike the bulk of B cells in the adult, which bear high levels (12) . Furthermore, CD5 expression is more frequent on B cells found early in ontogeny (13) .
It has been unclear whether these differences in B-cell phenotype reflect a stable feature of cells generated at different times in ontogeny or instead whether most B cells in the neonate are simply intermediates that have not yet matured into the adult type. Our previous cell transfer experiments showed that liver from newborn mice was much more effective in reconstituting CD5+ B cells when compared to bone marrow from adult mice (14) , suggesting that CD5+ B cells might arise from distinct precursors present in fetal liver but absent from adult bone marrow. However, since the IgDhigh B-cell population (IgD"+ B) was also generated in these newborn liver transfers, it was not established whether both types of differentiation were occurring simultaneously in the liver. Furthermore, the stage at which commitment to a particular B-cell phenotype (such as CD5+) has not been defined. Conceivably, this commitment might not take place until after the generation of an IgM' cell. To clarify these issues, our strategy has been first to identify B-cell progenitors in fetal liver and adult bone marrow and then to investigate whether they show a predisposition to generating phenotypically distinct types of B cells.
We recently found (15) that immature B-lineage cells in mouse bone marrow, defined as cells bearing the B-cellrestricted form of the common leukocyte antigen (CD45R, B220) (16) but lacking surface IgM expression, could be fractionated further based on expression of sialophorin (CD43). CD43 is a glycoprotein present on peripheral T, but not B, cells (17) . However, the earliest B-lineage cells in bone marrow do express CD43 and so are resolvable from later stage pre-B and B cells as a B220'CD43' fraction, constituting 3% of bone marrow. Cells in this fraction express variable levels of another surface molecule, the heat stable antigen (HSA) (18 
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Texas Red-avidin as described (15) . Sort gates are drawn on the plots in Fig. 1 , which present contours enclosing equal probabilities of cells (5%). Fig. 1 Inset shows the HSA distribution, which is also gated on an intermediate level of expression; any anti-Thy-i-stained cells (data not shown) were excluded. Sorted cells represent 1% offetal liver and 2% of bone marrow. Reanalysis of sorted fractions showed purities in excess of 95%. DNA was prepared from 1-2 x 10-cells, and regions 5' of DFL16.1, 5' of heavy-chain joining region 1 (JH1), and within the actin gene were amplified by using oligonucleotide primers described previously (15) . One-fifth of the total sample was used for a PCR reaction. Ten-microliter aliquots (one-tenth ofthe reaction) were withdrawn after 18 and 22 cycles, size fractionated on 1.5% agarose gels, blotted, and then probed and scanned to reveal levels of DNA produced. Probes used were generated by cloning the PCR products into the Sma I site of pBSM13-(Stratagene), which permitted generation of high specific activity RNA transcripts. DNA from adult liver served as a nonrearranged standard (for determination of percent retention of the germ line). DNA from two Abelson murine leukemia virus-transformed lines (1-8 with VDJ/DJ and 3-1 with VDJ/VDJ) was used to demonstrate the specificity of the assay. The reliability of this method for determining the rearrangement status of immunoglobulin genes was evaluated in a previous publication from this laboratory (15) .
Pro-B Stromal Cultures. Pro-B cells (B220CD43+HSA+) were sorted onto preestablished layers of the FLST2 line as described (15) . Medium (RPMI 1640 supplemented with 50 juM 2-mercaptoethanol and 5% fetal calf serum) was replenished at 4-day intervals. Cells recovered from the stromal layer after 10-14 days were stained with fluorescein-labeled anti-IgM (331.12) and allophycocyanin-labeled anti-CD5(53-7) plus propidium iodide (1 Ag/ml) to exclude dead cells and then analyzed on the cell sorter.
Pro-B Cell Transfers. Cells (105) in the pro-B fractions from day 16 fetal liver or adult bone marrow of BALB/c mice isolated as described in Fig. 1 were injected i.v. into SCID mice irradiated (300 R) the previous day. Three weeks after transfer, single-cell suspensions of spleen or peritoneal washout cells (14, 19) were prepared and stained with either a mixture offluorescein-labeled anti-IgM (331.12) and allophycocyanin-labeled anti-IgD (AMS-15.1) or fluorescein-labeled anti-IgM and allophycocyanin-labeled anti-CD5 (53-7) and then analyzed on a flow cytometer (FACStar PLUS, Becton Dickinson). This early time point was chosen to minimize clonal proliferation and the effects of differential cell survival, thereby providing a more uniform progeny. Pre-B cells (B220'CD43-; ref. 15) were absent from the bone marrow of recipients >2 months after cell transfer (data not shown). These animals differed from those reconstituted with unseparated or hemopoietic stem cell-enriched fractions where continuous generation of B-and T-lineage cells (and other cell types) from precursors has been suggested (20) . Consequently, we find that using pro-B cells requires 100-1000 times more cells (104-10W cells) to obtain significant levels (>5%) of peripheral B-cell generation as compared to that seen with stem cell-enriched fractions. Analysis with allotype-specific anti-IgM reagents (anti-IgMa, RS3.1; anti-IgMb, AF6-78) showed that all B cells were ofdonor BALB/c origin (data not shown).
Analysis of Antigen Binding by Flow Cytometry. Phosphatidylcholine (PC)-containing vesicles incorporating the fluorescent dye Texas Red were produced following a published procedure (32 Table 1 ). HO, a germ line heavy-chain gene. Table 1 are the average and standard error from 14 determinations (five PCR amplifications). Since cells in this fraction have initiated, but not completed, heavy-chain gene rearrangement, we classify them as pro B.
DNA isolated from this fraction from day 16 gestation liver shows somewhat less D-J rearrangement than that from adult bone marrow. However, expression of BP-1/6C3 (data not shown), a cell surface molecule that appears after initiation of D-J rearrangement, suggests that this day 16 fraction corresponds to the earlier (BP1/6C3-) pro-B cell stage in bone marrow (15) . This interpretation is further supported by the fact that we detect less rearrangement (and fewer BP1/6C3' cells) on day 15 and more rearrangement (together with a higher proportion of BP1/6C3' cells) on day 17. Therefore, these B220'CD43' cells in fetal liver appear to progress as a cohort through B-lineage differentiation.
Differentiative Potential of Pro-B Cells in Vito. We have compared the differentiative potential of this pro-B cell fraction from fetal liver with that of pro-B cells in the bone marrow of adult animals. First we employed a defined in vitro system. Early B-lineage cells can undergo limited B-cell differentiation when cultured on certain cloned adherent stromal cell lines (21, 22) . B220'CD43+HSA' (pro-B) cells from both adult and fetal sources generate IgM' B cells at similar frequencies during short-term culture on a stromal layer. However, as shown in Fig. 2 , the majority of fetalderived B cells express CD5, whereas the majority of bone Differentiative Potenthl of Pro-B Cels in Vivo. Cell transfer into irradiated immunodeficient SCID mice (23) provides an environment for lymphoid differentiation, one that permits generation of mature cells (ref. 24 , unpublished results). We therefore transferred limiting numbers of pro-B fractions from fetal and adult BALB/c mice into SCID mice and then examined the phenotype of lymphocytes generated in the periphery 3 weeks after cell transfer (Fig. 3) . Since distinct subpopulations of B cells are identifiable in spleen and peritoneal cavity (19) , we focused our analysis on these locations. FACS analysis of spleen and peritoneal cavity (PerC) cells revealed B-cell progenitor activity: IgM' B cells could be readily found in the recipients, whereas T cells (CD5+IgM-) were undetectable (<1%) in spleen and peritoneal cavity (Fig. 3 A, B , E, and F), and the thymus was not reconstituted (data not shown). These transferred pro-B cells differentiate in the recipients and do not establish a selfreplenishing pro-B population in spleen or bone marrow. Similar numbers of B cells were recovered in the two types of transfers from both locations (see Table 2 ). All recipients receiving day 16 fetal pro-B cells generated CD5' B cells in both spleen and peritoneal cavity (Fig. 3 A and B) . Further, most B cells in these recipients express low levels ofIgD ( Fig.   3 C and D) . In contrast, CD5' B cells were not generated using adult pro-B cells (Fig. 3 E and F) , and most B cells in these animals expressed high levels of IgD (Fig. 3 G and H) . Thus, as is clear in Fig. 4, two Proc. Natl. Acad Sci. USA 88 (1991) Proc. Natl. Acad. Sci. USA 88 (1991) 11553 Number of independent determinations: 28 for fetal liver and 15 for bone marrow transfer using 105 pro-B cells. The percentages of cells reported within a lymphoid gate (excluding erythrocytes and granular cells) are as follows: for fetal liver transfer, 48.6% (±1.1%) and 27.0%o (±1.3%) of total cells fall within a lymphoid gate for spleen and peritoneal cells, respectively (mean and SE); for bone marrow transfers, the corresponding values are 47.0%o (±1.2%) and 18.1% (±1.4%). Cell recovery was typically 1-2 x 107 for spleen cells and 1-3 x 106 for PerC cells in both kinds of transfer. Cells were analyzed as in Fig. 3. emerged in both sites: CD5+IgDlow from the fetal pro-B cell transfer and CD5-IgDhJgh from the adult pro-B cell transfer.
Data from analyses of mice long after cell transfer (2-5 months) yielded essentially the same conclusion: no IgD"i& B-cell generation by fetal pro-B and no CD5' B-cell generation by adult pro-B transfer (data not shown). In summary, our data demonstrate that the differences in the two types of B cells generated from these two B-progenitor sources are due to characteristics inherent in each B-cell progenitor. This in situ generation of distinct B progenitors appears to be determined by critical developmental timing, since we have found that pro-B cells in the liver later than day 17 ofgestation sulting in the accumulation of B cells with these specificities. A striking example ofthis is the high frequency of B cells with reactivity to a determinant(s) on mouse erythrocytes revealed by treatment with the proteolytic enzyme bromelain (BrMRBC) (26) (27) (28) (29) (30) . These BrMRBC-specific B cells can also be recognized by their specific ability to bind vesicles containing PC (28, 31) , presumably one component of the antigenic determinant. As shown in (11) . Responsiveness to a variety of antigens is more limited at early developmental times, and the induction of immunological tolerance is more easily obtained in the fetal through neonatal period (10, 33) . In studies of B lymphocytes, functional differences in young animals are usually ascribed to the relative "immaturity" of 11554 Immunology: Hardy and Hayakawa the cells present in the lymphoid organs, with the implicit assumption that such cells have the potential to mature. However, the experiments described above demonstrate that fetal and adult pro-B cells show a reciprocal ability in generating CD5' and IgDh'O B cells. Thus, we suggest that functional distinctions previously documented can be ascribed to physiological differences inherent in each type of B cell.
In both mouse and humans, the 67-kDa glycoprotein known as CD5 is largely restricted to T cells. In adult mice, most B cells in the peripheral lymphoid organs lack CD5 and bear high levels of IgD (CD5-IgD" 'h) (34) , whereas CD5' B cells are found at readily detectable levels only in restricted anatomical sites-for example, the peritoneal cavity (19) . These CD5' B cells are also characterized by low levels of IgD and exhibit functional differences from CD5-IgDO B cells, which has led us to consider them a distinct B-cell subset in mice, originally termed Ly-1 B (35) . Our current findings demonstrate that CD5 expression on B cells arises frequently in the course of fetal pro-B cell differentiation and that all progeny of B-lineage differentiation in early ontogeny possess a distinctive surface phenotype. Thus, it appears likely that CD5 expression serves to mark a population of fetal-derived B cells in a similar fashion as the y chain of hemoglobin marks a fetal-derived erythrocyte (4).
We found here that a characteristic specificity of CD5' B cells, to BrMRBC (PC), is enriched in SCID mice repopulated with pro-B cells from fetal liver but not adult bone marrow.
Thus, a functional CD5' B population is generated selectively from fetal pro-B cells, suggesting that B cells generated early in ontogeny can persist through life as a part ofthe adult immune system. However, the process whereby the CD5' B repertoire of adult mice is formed from the primary repertoire of the fetal and early postnatal periods is not known. We speculate that, in the absence of continuing replenishment from unrearranged precursors, the adult CD5' B-cell population consists predominantly of long-lived self-renewing cells and that recruitment into this pool requires antigenic selection. However, this remains to be proven. Further, whether the distinctive specificities enriched in the CD5' population (such as anti-BrMRBC) are deleted from the bone marrow-derived B-cell population, or simply not expanded, remains to be determined.
Why would B cells that differ from the adult type be generated fetally? One possibility would be to allow for the generation of B cells with reactivities that might otherwise be eliminated. We have noted previously that certain (likely beneficial) reactivities to self and environmental determinants are uniquely enriched in the CD5+ B-cell population (25) (26) (27) . Exposure to antigen during the differentiation of the adult B-cell population probably leads to functional inactivation ("anergy") or deletion as suggested by experiments with transgenic mice (36, 37) . In a young animal, the B-cell population is in the process of being generated and so infection at this time might fail to induce a response. If instead, germ-line-encoded specificities to common pathogens lead to positive selection in fetal-derived B cells, then such cells would serve as an early protective population, an inherited immune system. A difference in positive selection for germ-line-encoded self-reactivities between CD5+ and CD5-IgDhiO B cells would likely be due to physiological distinctions between fetal and adult B cells. Animals repopulated using pro-B cells derived from different stages of ontogeny will provide an experimental system for asking such questions. Finally, a comparison of the functional properties and genes expressed in pro-B cells at these two developmental stages will help to determine the mechanism for generating such distinctive progeny.
